Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
12.20
+0.58 (4.99%)
At close: Sep 11, 2026, 4:00 PM EDT
12.28
+0.08 (0.66%)
After-hours: Sep 11, 2026, 7:30 PM EDT
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $128.67 million as of September 11, 2026. Its market cap has increased by 34.73% in one year.
Market Cap
128.67M
Enterprise Value
73.94M
1-Year Change
34.73%
Ranking
Category
Stock Price
$12.20
ChartMarket Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $128.67M, a decrease of -94.87%. That is a compound annual growth rate of -37.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 128.67M | -40.69% |
| Dec 31, 2025 | 216.95M | 213.30% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OPKO Health | 1.19B |
| Castle Biosciences | 1.00B |
| Fulgent Genetics | 555.81M |
| Myriad Genetics | 304.17M |
| Biodesix | 280.98M |
| Exagen | 176.84M |
| Insight Molecular Diagnostics | 139.73M |
| Quantum Cyber | 119.38M |